Reference of 5181-35-1,Some common heterocyclic compound, 5181-35-1, name is 2-(2-Bromoethoxy)isoindoline-1,3-dione, molecular formula is C10H8BrNO3, traditional synthetic route has been very mature, but the traditional synthetic route has various shortcomings, such as complicated route, low yield, poor purity, etc, below Introduce a new synthetic route.
To a clean dry flask containing suspension of 2-(2-bromoethoxy)isoindoline- l,3-dione (30 g, 0.111 mol), 1H- 1,2,3 triazole (7.66 g, 111 mmol) in dimethylformamide (150 ml) was added cesium carbonate ((36 g, 111 mmol) portion wise at room temperature under stirring. After 17 hours, the reaction mixture was filtered and filtrate was slowly poured into chilled water (1050 ml) under stirring. After 30 minutes of stirring, the separated precipitates were collected by filtration and washed with water (100 ml). The collected precipitates were dried at 40 C for 2 hours under high vacuum to obtain 18.5 g of a mixture of 2-[2-(2H- l,2,3-triazol-2-yl)ethoxy]- lH-isoindole- l,3(2H)-dione and 2-[2- (lH- l,2,3-triazol- l-yl)ethoxy]- lH-isoindole- l,3(2H)-dione as a white compound in 65% yield. Analysis: Mass: 259.2 (M+l); for Molecular weight: 258 and Molecular formula: C12H10N4O3; To a solution of mixture of 2-(2-(2H-l,2,3-triazol-2- yl)ethoxy)isoindoline-l,3-dione and 2-(2-(lH-l,2,3-triazol-l-yl)ethoxy)isoindoline-l,3-dione (13 g, 50.3 mmol, obtained from Step 1) in dichloromethane (130 ml) was added hydrazine hydrate (3.7 ml, 75.7 mmol) under stirring at room temperature. After 2 hours, the progress of reaction was monitored by thin layer chromatography using mixture of chloroform and methanol as solvent system. After completion of the reaction the unwanted solid was filtered out and washed with dichloromethane (25 ml). The collective filtrates were concentrated at 40 C under high vacuum to dryness to provide 6.5 g of a mixture of 2-[2-(aminooxy)ethyl]-2H-l,2,3-triazole and l-[2- (aminooxy)ethyl]-lH-l,2,3-triazole, which was used as such in the next step without any further purification; To a solution of sodium salt of (25,5 ?)-6-(benzyloxy)-7-oxo-l,6-diaza-bicyclo[3.2.1]octane-2-carboxylic acid (15 g, 54.3 mmol, prepared as per the procedure disclosed in International Patent Application No. PCT/IB2013/059264) in dimethylformamide (75 ml) was added EDC.HC1 (15.6 g, 81.6 mmol) at ambient temperature under stirring. Then N-methyl morpholine (16.5 ml, 0.150 moles) was added followed by HOBT (7.73 g, 50.7 mmol) and reaction mixture was stirred for 5 minutes at ambient temperature. To this reaction mixture was added a solution of mixture of 2-[2-(aminooxy)ethyl]- 2H-l,2,3-triazole and l-[2-(aminooxy)ethyl]-lH-l,2,3-triazole (6.5 g, product from Step 2) in dimethylformamide (6.5 ml) under stirring at 15 C and then allowed to attain room temperature. The progress of reaction was monitored by thin layer chromatography using mixture of chloroform and methanol (9: 1) as solvent system. After completion of the reaction (17 hours), the resulted reaction mixture was slowly poured into chilled water (500 ml) and extracted with ethyl acetate (2×150 ml). The combined organic layer was washed with brine (75 ml) and organic layer was dried over anhydrous sodium sulfate, concentrated on rotavapour to provide 17.5 g of crude compound. It was purified by column chromatography (silica gel 60-120 mesh) using mixture of hexane and acetone as an eluent. The upper spot containing fractions were collected at 30-40% concentration of acetone in hexane and concentrated to dryness under vacuum to provide7.5 g of (25,5 ?)-6-(benzyloxy)-7-oxo-N-[2-(2H-l,2,3-triazol-2-yl)ethoxy]-l,6-diazabicyclo [3.2.1]octane-2- carboxamide. Similarly lower spot containing fractions collected at 40-50% concentration of acetone in hexane were concentrated to dryness under vacuum to provide 5.2 g of of (25,5 ?)-6- (benzyloxy)-7-oxo-N-[2-(lH-l,2,3-triazol-l-yl)ethoxy]-l,6-diazabicyclo[3.2.1]octane-2- carboxamide. In total, 12.7 g was obtained in 70% yield. Analysis: Mass: 385.3 (M-l); for Molecular weight: 386 and Molecular formula: C18H22N6O4.
These compound has a wide range of applications. It is believed that with the continuous development of the source of the synthetic route 2-(2-Bromoethoxy)isoindoline-1,3-dione, its application will become more common.
Reference:
Patent; WOCKHARDT LIMITED; TADIPARTHI, Ravikumar; PATIL, Vijaykumar Jagdishwar; DEKHANE, Deepak; SHAIKH, Mohammad Usman; BIRAJDAR, Satish; DOND, Bharat; PATEL, Mahesh Vithalbhai; (100 pag.)WO2017/81615; (2017); A1;,
Indoline – Wikipedia,
Indoline | C8H9N – PubChem